Invesco India Pharma And Healthcare Fund Direct Growth | New Fund Listing | NFO MF | New NFO

Invesco India Pharma And Healthcare Fund Direct Growth
Very High Risk
Launch date18 Aug 2026
Allotment date07 Sep 2026
End date01 Sep 2026
NAV₹10.00
Understand termsExpense ratioA fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
TaxA percentage of your capital gains payable to the government upon exiting  your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
Exit loadA fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
Stamp dutyA form of tax payable for the purchase or sale of an asset or security. 
Expense ratio, exit load and taxExpense ratio: --Inclusive of GST
Exit loadExit load of 0.50%, if redeemed within 3 months.
Stamp duty0.005% (from July 1st, 2020)
Tax implication--
Understand terms
Minimum investment amountsMin. for 1st investment₹1,000
Min. for 2nd investment onwards₹1,000
Min. for SIP₹100
Fund house & investment objective
Invesco Mutual Fund
Rank (total assets)#16 in India
Total AUM₹1,60,871.38Cr
Date of Incorporation24 Jul 2006
    Invesco India Pharma And Healthcare Fund Direct Growth is a -- Mutual Fund Scheme launched by Invesco Mutual Fund.     This scheme was made available to investors on 24 Jul 2006.     Aditya Khemani is the Current Fund Manager of Invesco India Pharma And Healthcare Fund Direct Growth fund.     The fund currently has an Asset Under Management(AUM) of ₹1,60,871 Cr and     the Latest NAV as of 18 Aug 2026 is ₹10.00.  

    The Invesco India Pharma And Healthcare Fund Direct Growth is rated Very High risk.     Minimum SIP Investment is set to ₹100.     Minimum Lumpsum Investment is ₹1,000.     Exit load of 0.50%, if redeemed within 3 months.
  ;
Investment ObjectiveThe scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors 
 
;
Fund benchmarkBSE Healthcare Total Return Index
Scheme Information Document(SID)
Fund house contact details
Address
B-1001, B Wing, 10th Floor, Marathon Futurex,N. M. Joshi Marg, Lower Parel,Mumbai, Maharashtra Mumbai 400013
Phone
+91 022-67310000
Launch Date
24 Jul 2006
E-mail
--
Website
www.invescomutualfund.com
Peer ComparisonFund nameRating1Y3YFund Size(Cr)
Franklin India Mid Cap Fund Direct Growth
2
8.1%18.9%12,870.79
Nippon India Small Cap Fund Direct Growth
4
13.1%17.9%78,956.77
Franklin India Small Cap Fund Direct Growth
3
10.5%15.9%14,466.52
HDFC Small Cap Fund Direct Growth
3
2.7%13.2%41,679.00
Franklin India Technology Fund Direct Growth
--
-3.0%12.0%1,753.91

Rank (total assets)	#16 in India
Total AUM	₹1,60,871.38Cr

Date of Incorporation	24 Jul 2006

Fund benchmark	BSE Healthcare Total Return Index

Fund name	Rating	1Y	3Y	Fund Size(Cr)
Franklin India Mid Cap Fund Direct Growth	2	8.1%	18.9%	12,870.79
Nippon India Small Cap Fund Direct Growth	4	13.1%	17.9%	78,956.77
Franklin India Small Cap Fund Direct Growth	3	10.5%	15.9%	14,466.52
HDFC Small Cap Fund Direct Growth	3	2.7%	13.2%	41,679.00
Franklin India Technology Fund Direct Growth	--	-3.0%	12.0%	1,753.91